Intracrine oestrogen production and action in breast cancer: An epigenetic focus

Journal of Steroid Biochemistry and Molecular Biology

Volumn 137, Issue , 2013, Pages 157-164

  Knower, Kevin C ^a   To, Sarah Q ^a,b   Clyne, Colin D ^a,b  

^a HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Aromatase; DNA methylation; Endocrine therapy; Epigenetics; Oestrogen biosynthesis; Postmenopausal breast cancer

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; AZACITIDINE; BUTYRIC ACID; ENTINOSTAT; ENZYME; ESTROGEN; EXEMESTANE; HYDROXAMIC ACID; LETROZOLE; PANOBINOSTAT; TAMOXIFEN; TRICHOSTATIN A; VORINOSTAT;

BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; EPIGENETICS; ESTROGEN SYNTHESIS; GENETIC REGULATION; GENETIC RESISTANCE; HORMONAL THERAPY; HORMONE ACTION; HORMONE SYNTHESIS; HUMAN; MOLECULAR DYNAMICS; NONHUMAN; POSTMENOPAUSE; REVIEW;

AROMATASE; DNA METHYLATION; ENDOCRINE THERAPY; EPIGENETICS; OESTROGEN BIOSYNTHESIS; POSTMENOPAUSAL BREAST CANCER;

ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; EPIGENESIS, GENETIC; ESTROGENS; FEMALE; HUMANS;

EID: 84886599269     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2013.01.009     Document Type: Review

References (146)

1. J.D. Yager, and N.E. Davidson Estrogen carcinogenesis in breast cancer New England Journal of Medicine 354 3 2006 270 282
2. H. Sasano Functional pathology of human ovarian steroidogenesis: normal cycling ovary and steroid-producing neoplasms Endocrine Pathology 5 2 1994 81 89 (Pubitemid 2096869)
3. H.U. Schweikert, L. Milewich, and J.D. Wilson: Aromatization of androstenedione by cultured human fibroblasts Journal of Clinical Endocrinology and Metabolism 43 4 1976 785 795
4. C. Longcope, J.H. Pratt, H.S. Stephen, and S.E. Fineberg Aromatization of androgens by muscle and adipose tissue in vivo Journal of Clinical Endocrinology & Metabolism 46 1 1978 146 152 (Pubitemid 8295359)
5. H. Sasano, M. Uzuki, T. Sawai, H. Nagura, G. Matsunaga, O. Kashimoto, and N. Harada Aromatase in human bone tissue Journal of Bone and Mineral Research 12 9 1997 1416 1423 (Pubitemid 27375384)
6. A. Balthazart, J. Fau Foidart, N. Foidart, A. Fau Harada, and N. Harada Immunocytochemical localization of aromatase in the brain Brain Research 524 1990 327 333 (Pubitemid 20151384)
7. F. Cardoso, J. Bischoff, E. Brain, Á.G. Zotano, H.-J. Lück, V.C. Tjan-Heijnen, M. Tanner, and M. Aapro A review of the treatment of endocrine responsive metastatic breast cancer in postmenopausal women Cancer Treatment Reviews 2012 1 9 10.1016/j.ctrv.2012.06.011
8. R.W. Brueggemeier, J.C. Hackett, and E.S. Diaz-Cruz Aromatase inhibitors in the treatment of breast cancer Endocrine Reviews 26 3 2005 331 345 (Pubitemid 40686647)
9. S.R. Stecklein, R.A. Jensen, and A. Pal Genetic and epigenetic signatures of breast cancer subtypes Frontiers in Bioscience (Elite Edition) 4 2012 934 949
10. B. Li, M. Carey, and J.L. Workman The role of chromatin during transcription Cell 128 4 2007 707 719 (Pubitemid 46273570)
11. M. Noyer-Weidner, and T.A. Trautner Methylation of DNA in prokaryotes EXS 64 1993 39 108
12. F. Hutchinson Use of data from bacteria to interpret data on DNA damage processing in mammalian cells Mutation Research 220 2-3 1989 269 278 (Pubitemid 19078878)
13. A. Razin, and A.D. Riggs DNA methylation and gene function Science 210 4470 1980 604 610
14. K.D. Robertson DNA methylation and chromatin - unraveling the tangled web Oncogene 21 35 2002 5361 5379 (Pubitemid 34983473)
15. J.S. You, and P.A. Jones Cancer genetics and epigenetics: two sides of the same coin? Cancer Cell 22 1 2012 9 20
16. X. Nan, H.H. Ng, C.A. Johnson, C.D. Laherty, B.M. Turner, R.N. Eisenman, and A. Bird Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex Nature 393 6683 1998 386 389 (Pubitemid 28269714)
17. M. Demura, and S.E. Bulun CpG dinucleotide methylation of the CYP19 I.3/II promoter modulates cAMP-stimulated aromatase activity Molecular and Cellular Endocrinology 283 1-2 2008 127 132
18. J. Song, M. Teplova, S. Ishibe-Murakami, and D.J. Patel Structure based mechanistic insights into DNMT1 mediated maintenance DNA methylation Science 335 6069 2012 709 712
19. M. Okano, D.W. Bell, D.A. Haber, and E. Li DNA methyltransferases DNMT3A and DNMT3B are essential for de novo methylation and mammalian development Cell 99 3 1999 247 257 (Pubitemid 29519904)
20. P.A. Jones, and G. Liang Rethinking how DNA methylation patterns are maintained Nature Reviews Genetics 10 11 2009 805 811
21. Y. Kanai, S. Ushijima, Y. Nakanishi, M. Sakamoto, and S. Hirohashi Mutation of the DNA methyltransferase (DNMT) 1 gene in human colorectal cancers Cancer Letters 192 1 2003 75 82 (Pubitemid 36292165)
22. S. Masuda DNMT3A mutations in acute myeloid leukemia: impact on low-risk patients with CEBPA mutations Journal of Clinical Oncology 29 34 2012 4593 4594 4592-4593; author reply
23. X.J. Yan, J. Xu, Z.H. Gu, C.M. Pan, G. Lu, Y. Shen, J.Y. Shi, Y.M. Zhu, L. Tang, and X.W. Zhang Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia Nature Genetics 43 4 2011 309 315
24. Y. Wu, E. Strawn, Z. Basir, G. Halverson, and S.W. Guo Aberrant expression of deoxyribonucleic acid methyltransferases DNMT1 DNMT3A, and DNMT3B in women with endometriosis Fertility and Sterility 87 1 2007 24 32 (Pubitemid 46013877)
25. N. Bhutani, D.M. Burns, and H.M. Blau DNA demethylation dynamics Cell 146 6 2011 866 872
26. M. Tahiliani, K.P. Koh, Y. Shen, W.A. Pastor, H. Bandukwala, Y. Brudno, S. Agarwal, L.M. Iyer, D.R. Liu, and L. Aravind Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1 Science 324 5929 2009 930 935
27. H.D. Morgan, W. Dean, H.A. Coker, W. Reik, and S.K. Petersen-Mahrt Activation-induced cytidine deaminase deaminates 5-methylcytosine in DNA and is expressed in pluripotent tissues: implications for epigenetic reprogramming Journal of Biological Chemistry 279 50 2004 52353 52360 (Pubitemid 39656611)
28. Y.F. He, B.Z. Li, Z. Li, P. Liu, Y. Wang, Q. Tang, J. Ding, Y. Jia, Z. Chen, and L. Li TET-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA Science 333 6047 2011 1303 1307
29. V. Valinluck, and L.C. Sowers Endogenous cytosine damage products alter the site selectivity of human DNA maintenance methyltransferase DNMT1 Cancer Research 67 3 2007 946 950
30. L. Cimmino, O. Abdel-Wahab, R.L. Levine, and I. Aifantis TET family proteins and their role in stem cell differentiation and transformation Cell Stem Cell 9 3 2011 193 204
31. F. Lemonnier, L. Couronne, M. Parrens, J.P. Jais, M. Travert, L. Lamant, O. Tournillac, T. Rousset, B. Fabiani, and R.A. Cairns Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters Blood 120 7 2012 1466 1469
32. V.I. Gaidzik, P. Paschka, D. Spath, M. Habdank, C.H. Kohne, U. Germing, M. von Lilienfeld-Toal, G. Held, H.A. Horst, and D. Haase TET2 mutations in acute myeloid leukemia (AML): results from a comprehensive genetic and clinical analysis of the AML study group Journal of Clinical Oncology 30 12 2012 1350 1357
33. J. Boyes, and A. Bird Repression of genes by DNA methylation depends on CpG density and promoter strength: evidence for involvement of a methyl-CpG binding protein EMBO Journal 11 1 1992 327 333
34. N. Reichert, M.A. Choukrallah, and P. Matthias Multiple roles of class I HDACs in proliferation, differentiation, and development Cellular and Molecular Life Sciences 69 13 2012 2173 2187
35. C. Choudhary, C. Kumar, F. Gnad, M.L. Nielsen, M. Rehman, T.C. Walther, J.V. Olsen, and M. Mann Lysine acetylation targets protein complexes and co-regulates major cellular functions Science 325 5942 2009 834 840
36. S.D. Furdas, S. Kannan, W. Sippl, and M. Jung Small molecule inhibitors of histone acetyltransferases as epigenetic tools and drug candidates Archiv der Pharmazie 345 1 2012 7 21
37. G. Hon, W. Wang, and B. Ren Discovery and annotation of functional chromatin signatures in the human genome PLoS Computational Biology 5 11 2009 e1000566
38. G.C. Hon, R.D. Hawkins, and B. Ren Predictive chromatin signatures in the mammalian genome Human Molecular Genetics 18 R2 2009 R195 R201
39. D. Nathan, K. Ingvarsdottir, D.E. Sterner, G.R. Bylebyl, M. Dokmanovic, J.A. Dorsey, K.A. Whelan, M. Krsmanovic, W.S. Lane, and P.B. Meluh Histone sumoylation is a negative regulator in Saccharomyces cerevisiae and shows dynamic interplay with positive-acting histone modifications Genes and Development 20 8 2006 966 976
40. S.J. Nowak, and V.G. Corces Phosphorylation of histone H3: a balancing act between chromosome condensation and transcriptional activation Trends in Genetics 20 4 2004 214 220 (Pubitemid 38369193)
41. H. Wang, L. Wang, H. Erdjument-Bromage, M. Vidal, P. Tempst, R.S. Jones, and Y. Zhang Role of histone H2A ubiquitination in polycomb silencing Nature 431 7010 2004 873 878 (Pubitemid 39434086)
42. I.A. Qureshi, and M.F. Mehler Emerging roles of non-coding RNAs in brain evolution, development, plasticity and disease Nature Reviews. Neuroscience 13 8 2012 528 541
43. T. Hung, Y. Wang, M.F. Lin, A.K. Koegel, Y. Kotake, G.D. Grant, H.M. Horlings, N. Shah, C. Umbricht, and P. Wang Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters Nature Genetics 43 7 2011 621 629
44. A.M. Khalil, M. Guttman, M. Huarte, M. Garber, A. Raj, D. Rivea Morales, K. Thomas, A. Presser, B.E. Bernstein, and A. van Oudenaarden Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression Proceedings of the National Academy of Sciences of the United States of America 106 28 2009 11667 11672
45. O. Rackham, A.M. Shearwood, T.R. Mercer, S.M. Davies, J.S. Mattick, and A. Filipovska Long noncoding RNAs are generated from the mitochondrial genome and regulated by nuclear-encoded proteins RNA 17 12 2011 2085 2093
46. O. Wapinski, and H.Y. Chang Long noncoding RNAs and human disease Trends in Cell Biology 21 6 2011 354 361
47. M. Lagos-Quintana, R. Rauhut, W. Lendeckel, and T. Tuschl Identification of novel genes coding for small expressed RNAs Science 294 5543 2001 853 858 (Pubitemid 33032103)
48. K. Okamura, W.J. Chung, J.G. Ruby, H. Guo, D.P. Bartel, and E.C. Lai The drosophila hairpin RNA pathway generates endogenous short interfering RNAs Nature 453 7196 2008 803 806 (Pubitemid 351793790)
49. V.N. Kim Small RNAs just got bigger: piwi-interacting RNAs (piRNAs) in mammalian testes Genes and Development 20 15 2006 1993 1997 (Pubitemid 44157450)
50. W.R. Miller, R.A. Hawkins, and A.P. Forrest Significance of aromatase activity in human breast cancer Cancer Research 42 8 (Suppl.) 1982 3365s 3368s (Pubitemid 12022725)
51. W.R. Miller Aromatase activity in breast tissue Journal of Steroid Biochemistry and Molecular Biology 39 5B 1991 783 790
52. T. Suzuki, T. Moriya, N. Ariga, C. Kaneko, M. Kanazawa, and H. Sasano 17Beta-hydroxysteroid dehydrogenase type 1 and type 2 in human breast carcinoma: a correlation to clinicopathological parameters British Journal of Cancer 82 3 2000 518 523 (Pubitemid 30085183)
53. J.R. Pasqualini, C. Gelly, and F. Lecerf Estrogen sulfates: biological and ultrastructural responses and metabolism in MCF-7 human breast cancer cells Breast Cancer Research and Treatment 8 3 1986 233 240 (Pubitemid 17073482)
54. T. Suzuki, T. Nakata, Y. Miki, C. Kaneko, T. Moriya, T. Ishida, S. Akinaga, H. Hirakawa, M. Kimura, and H. Sasano Estrogen sulfotransferase and steroid sulfatase in human breast carcinoma Cancer Research 63 11 2003 2762 2770 (Pubitemid 36667146)
55. E.R. Simpson Aromatase: biologic relevance of tissue-specific expression Seminars in Reproductive Medicine 22 1 2004 11 23 (Pubitemid 38524580)
56. C.J. Fabian The what, why and how of aromatase inhibitors: hormonal agents for treatment and prevention of breast cancer International Journal of Clinical Practice 61 12 2007 2051 2063 (Pubitemid 350077408)
57. P.E. Lonning, J. Geisler, L.E. Krag, B. Erikstein, Y. Bremnes, A.I. Hagen, E. Schlichting, E.A. Lien, E.S. Ofjord, and J. Paolini Effects of exemestane administered for 2 years versus placebo on bone mineral density, bone biomarkers, and plasma lipids in patients with surgically resected early breast cancer Journal of Clinical Oncology 23 22 2005 5126 5137 (Pubitemid 46224021)
58. E.A. Perez, R.G. Josse, K.I. Pritchard, J.N. Ingle, S. Martino, B.P. Findlay, T.N. Shenkier, R.G. Tozer, M.J. Palmer, and L.E. Shepherd Effect of letrozole versus placebo on bone mineral density in women with primary breast cancer completing 5 or more years of adjuvant tamoxifen: a companion study to NCIC CTG MA.17 Journal of Clinical Oncology 24 22 2006 3629 3635 (Pubitemid 46630537)
59. D. Chen, S. Reierstad, M. Lu, Z. Lin, H. Ishikawa, and S.E. Bulun Regulation of breast cancer-associated aromatase promoters Cancer Letters 273 1 2009 15 27
60. A.L. Chand, K.A. Herridge, T.L. Howard, E.R. Simpson, and C.D. Clyne Tissue-specific regulation of aromatase promoter II by the orphan nuclear receptor LRH-1 in breast adipose stromal fibroblasts Steroids 76 8 2011 741 744
61. C.D. Clyne, A. Kovacic, C.J. Speed, J. Zhou, V. Pezzi, and E.R. Simpson Regulation of aromatase expression by the nuclear receptor LRH-1 in adipose tissue Molecular and Cellular Endocrinology 215 1-2 2004 39 44 (Pubitemid 38333241)
62. C.D. Clyne, C.J. Speed, J. Zhou, and E.R. Simpson Liver receptor homologue-1 (LRH-1) regulates expression of aromatase in preadipocytes Journal of Biological Chemistry 277 23 2002 20591 20597 (Pubitemid 34967360)
63. K.C. Knower, S.Q. To, K. Takagi, Y. Miki, H. Sasano, E.R. Simpson, and C.D. Clyne Melatonin suppresses aromatase expression and activity in breast cancer associated fibroblasts Breast Cancer Research and Treatment 132 2 2012 765 771
64. A. Kovacic, C.J. Speed, E.R. Simpson, and C.D. Clyne Inhibition of aromatase transcription via promoter II by short heterodimer partner in human preadipocytes Molecular Endocrinology 18 1 2004 252 259 (Pubitemid 38073169)
65. G.L. Rubin, J.H. Duong, C.D. Clyne, C.J. Speed, Y. Murata, C. Gong, and E.R. Simpson Ligands for the peroxisomal proliferator-activated receptor gamma and the retinoid X receptor inhibit aromatase cytochrome P450 (CYP19) expression mediated by promoter II in human breast adipose Endocrinology 143 8 2002 2863 2871 (Pubitemid 34809856)
66. R. Safi, A. Kovacic, S. Gaillard, Y. Murata, E.R. Simpson, D.P. McDonnell, and C.D. Clyne Coactivation of liver receptor homologue-1 by peroxisome proliferator-activated receptor gamma coactivator-1alpha on aromatase promoter II and its inhibition by activated retinoid X receptor suggest a novel target for breast-specific antiestrogen therapy Cancer Research 65 24 2005 11762 11770 (Pubitemid 41821738)
67. M. Sofi, M.J. Young, T. Papamakarios, E.R. Simpson, and C.D. Clyne Role of CRE-binding protein (CREB) in aromatase expression in breast adipose Breast Cancer Research and Treatment 79 3 2003 399 407 (Pubitemid 36750947)
68. E.R. Simpson, M. Misso, K.N. Hewitt, R.A. Hill, W.C. Boon, M.E. Jones, A. Kovacic, J. Zhou, and C.D. Clyne Estrogen - the good, the bad, and the unexpected Endocrine Reviews 26 3 2005 322 330 (Pubitemid 40686646)
69. S.E. Bulun, T.M. Price, J. Aitken, M.S. Mahendroo, and E.R. Simpson A link between breast cancer and local estrogen biosynthesis suggested by quantification of breast adipose tissue aromatase cytochrome P450 transcripts using competitive polymerase chain reaction after reverse transcription Journal of Clinical Endocrinology and Metabolism 77 6 1993 1622 1628 (Pubitemid 24000924)
70. N. Harada, T. Utsumi, and Y. Takagi Tissue-specific expression of the human aromatase cytochrome P-450 gene by alternative use of multiple exons 1 and promoters, and switching of tissue-specific exons 1 in carcinogenesis Proceedings of the National Academy of Sciences of the United States of America 90 23 1993 11312 11316 (Pubitemid 23354419)
71. M.S. Mahendroo, C.R. Mendelson, and E.R. Simpson Tissue-specific and hormonally controlled alternative promoters regulate aromatase cytochrome P450 gene expression in human adipose tissue Journal of Biological Chemistry 268 26 1993 19463 19470 (Pubitemid 23270727)
72. Y. Zhao, C.R. Mendelson, and E.R. Simpson Characterization of the sequences of the human CYP19 (aromatase) gene that mediate regulation by glucocorticoids in adipose stromal cells and fetal hepatocytes Molecular Endocrinology 9 3 1995 340 349
73. Y. Zhao, J.E. Nichols, S.E. Bulun, C.R. Mendelson, and E.R. Simpson Aromatase P450 gene expression in human adipose tissue. Role of a Jak/STAT pathway in regulation of the adipose-specific promoter The Journal of Biological Chemistry 270 27 1995 16449 16457
74. V.R. Agarwal, S.E. Bulun, M. Leitch, R. Rohrich, and E.R. Simpson Use of alternative promoters to express the aromatase cytochrome P450 (CYP19) gene in breast adipose tissues of cancer-free and breast cancer patients Journal of Clinical Endocrinology and Metabolism 81 11 1996 3843 3849 (Pubitemid 26380384)
75. N. Irahara, Y. Miyoshi, T. Taguchi, Y. Tamaki, and S. Noguchi Quantitative analysis of aromatase mRNA expression derived from various promoters (I.4, I.3, PII and I.7) and its association with expression of TNF-alpha IL-6 and COX-2 mRNAs in human breast cancer International Journal of Cancer 118 8 2006 1915 1921
76. D. Zhou, C. Zhou, and S. Chen Gene regulation studies of aromatase expression in breast cancer and adipose stromal cells Journal of Steroid Biochemistry and Molecular Biology 61 3-6 1997 273 280 (Pubitemid 27455689)
77. Y. Zhao, J.E. Nichols, R. Valdez, C.R. Mendelson, and E.R. Simpson Tumor necrosis factor-alpha stimulates aromatase gene expression in human adipose stromal cells through use of an activating protein-1 binding site upstream of promoter 1.4 Molecular Endocrinology 10 11 1996 1350 1357
78. R.W. Brueggemeier, A.L. Quinn, M.L. Parrett, F.S. Joarder, R.E. Harris, and F.M. Robertson Correlation of aromatase and cyclooxygenase gene expression in human breast cancer specimens Cancer Letters 140 1-2 1999 27 35 (Pubitemid 29251310)
79. M.P. Schrey, and K.V. Patel Prostaglandin E2 production and metabolism in human breast cancer cells and breast fibroblasts regulation by inflammatory mediators British Journal of Cancer 72 6 1995 1412 1419
80. H. Sasano, D.P. Edwards, T.J. Anderson, S.G. Silverberg, D.B. Evans, R.J. Santen, P. Ramage, E.R. Simpson, A.S. Bhatnagar, and W.R. Miller Validation of new aromatase monoclonal antibodies for immunohistochemistry: progress report Journal of Steroid Biochemistry and Molecular Biology 86 3-5 2003 239 244 (Pubitemid 37412563)
81. T. Suzuki, Y. Miki, J. Akahira, T. Moriya, N. Ohuchi, and H. Sasano Aromatase in human breast carcinoma as a key regulator of intratumoral sex steroid concentrations Endocrine Journal 55 3 2008 455 463 (Pubitemid 351949737)
82. M. Leshin 5-Azacytidine and sodium butyrate induce expression of aromatase in fibroblasts from chickens carrying the henny feathering trait but not from wild-type chickens Proceedings of the National Academy of Sciences of the United States of America 82 9 1985 3005 3009 (Pubitemid 15097781)
83. M. Izawa, F. Taniguchi, T. Uegaki, E. Takai, T. Iwabe, N. Terakawa, and T. Harada Demethylation of a nonpromoter cytosine-phosphate-guanine island in the aromatase gene may cause the aberrant up-regulation in endometriotic tissues Fertility and Sterility 95 1 2011 33 39
84. M. Izawa, T. Harada, F. Taniguchi, Y. Ohama, Y. Takenaka, and N. Terakawa An epigenetic disorder may cause aberrant expression of aromatase gene in endometriotic stromal cells Fertility and Sterility 89 5 (Suppl.) 2008 1390 1396 (Pubitemid 351680090)
85. L.O. Dannenberg, and H.J. Edenberg Epigenetics of gene expression in human hepatoma cells: expression profiling the response to inhibition of DNA methylation and histone deacetylation BMC Genomics 7 2006 181
86. K.I. Matsuda, H. Mori, B.M. Nugent, D.W. Pfaff, M.M. McCarthy, and M. Kawata Histone deacetylation during brain development is essential for permanent masculinization of sexual behavior Endocrinology 152 7 2011 2760 2767
87. G.J. Sabnis, O. Goloubeva, S. Chumsri, N. Nguyen, S. Sukumar, and A.M.H. Brodie Functional activation of the estrogen receptor-alpha and aromatase by the HDAC inhibitor entinostat sensitizes ER-negative tumors to letrozole Cancer Research 71 5 2011 1893 1903
88. S. Chen, J. Ye, I. Kijima, and D. Evans The HDAC inhibitor LBH589 (panobinostat) is an inhibitory modulator of aromatase gene expression Proceedings of the National Academy of Sciences of the United States of America 107 24 2010 11032 11037
89. M. Spitschak, and J. Vanselow Bovine large luteal cells show increasing de novo DNA methylation of the main ovarian CYP19A1 promoter P2 General and Comparative Endocrinology 178 1 2012 37 45
90. L. Lee, H. Asada, F. Kizuka, I. Tamura, R. Maekawa, T. Taketani, S. Sato, Y. Yamagata, H. Tamura, and N. Sugino Changes in histone modification and DNA methylation of the StAR and CYP19a1 promoter regions in Granulosa cells undergoing luteinization during ovulation in rats Endocrinology 2012
91. S. Ghai, R. Monga, T.K. Mohanty, M.S. Chauhan, and D. Singh Term placenta shows methylation independent down regulation of CYP19 gene in animals with retained fetal membranes Research in Veterinary Science 92 1 2012 53 59
92. H.L. Ellis, K. Shioda, N.F. Rosenthal, K.R. Coser, and T. Shioda Masculine epigenetic sex marks of the CYP19A1/aromatase promoter in genetically male chicken embryonic gonads are resistant to estrogen-induced phenotypic sex conversion Biology of Reproduction 87 1 2012 23-21-12
93. L. Navarro-Martín, J. Viñas, L. Ribas, N. Díaz, A. Gutiérrez, L. Di Croce, and F. Piferrer DNA methylation of the gonadal aromatase (CYP19a) promoter is involved in temperature-dependent sex ratio shifts in the European sea bass PLoS Genetics 7 12 2011 e1002447
94. R. Monga, S. Ghai, T.K. Datta, and D. Singh Tissue-specific promoter methylation and histone modification regulate CYP19 gene expression during folliculogenesis and luteinization in buffalo ovary General and Comparative Endocrinology 173 1 2011 205 215
95. J. Vanselow, M. Spitschak, M. Nimz, and R. Fürbass DNA methylation is not involved in preovulatory down-regulation of CYP11A1, HSD3B1, and CYP19A1 in bovine follicles but may have a role in permanent silencing of CYP19A1 in large granulosa lutein cells Biology of Reproduction 82 2 2010 289 298
96. S. Ghai, R. Monga, T.K. Mohanty, M.S. Chauhan, and D. Singh Tissue-specific promoter methylation coincides with CYP19 gene expression in buffalo (Bubalus bubalis) placenta of different stages of gestation General and Comparative Endocrinology 169 2 2010 182 189
97. J. Vanselow, R. Selimyan, and R. Fürbass DNA methylation of placenta-specific CYP19 promoters of cattle and sheep Experimental and Clinical Endocrinology & Diabetes 116 7 2008 437 442
98. R. Fürbass, R. Selimyan, and J. Vanselow DNA methylation and chromatin accessibility of the proximal CYP 19 promoter region 1.5/2 correlate with expression levels in sheep placentomes Molecular Reproduction and Development 75 1 2008 1 7 (Pubitemid 350223984)
99. J. Vanselow, R. Pohland, and R. Fürbass Promoter-2-derived CYP19 expression in bovine granulosa cells coincides with gene-specific DNA hypo-methylation Molecular and Cellular Endocrinology 233 1-2 2005 57 64 (Pubitemid 40568661)
100. R. Fürbass, H.M. Said, M. Schwerin, and J. Vanselow Chromatin structure of the bovine CYP19 promoter 1.1. DNaseI hypersensitive sites and DNA hypomethylation correlate with placental expression European Journal of Biochemistry/FEBS 268 5 2001 1222 1227 (Pubitemid 32231874)
101. Y. Shibahara, Y. Miki, Y. Onodera, S. Hata, M.S. Chan, C.C. Yiu, T.Y. Loo, Y. Nakamura, J. Akahira, and T. Ishida Aromatase inhibitor treatment of breast cancer cells increases the expression of LET-7f, a microRNA targeting CYP19A1 Journal of Pathology 227 3 2012 357 366
102. K.C. Knower, S.Q. To, E.R. Simpson, and C.D. Clyne Epigenetic mechanisms regulating CYP19 transcription in human breast adipose fibroblasts Molecular and Cellular Endocrinology 321 2 2010 123 130
103. A.A. Rawluszko, K. Horbacka, P. Krokowicz, and P.P. Jagodzinski Decreased expression of 17beta-hydroxysteroid dehydrogenase type 1 is associated with DNA hypermethylation in colorectal cancer located in the proximal colon BMC Cancer 11 2011 522
104. A.A. Rawluszko, P. Krokowicz, and P.P. Jagodzinski Butyrate induces expression of 17beta-hydroxysteroid dehydrogenase type 1 in HT29 and SW707 colorectal cancer cells DNA and Cell Biology 30 9 2011 661 669
105. S. Marchais-Oberwinkler, C. Henn, G. Moller, T. Klein, M. Negri, A. Oster, A. Spadaro, R. Werth, M. Wetzel, and K. Xu 17Beta-hydroxysteroid dehydrogenases (17beta-HSDs) as therapeutic targets: protein structures, functions, and recent progress in inhibitor development Journal of Steroid Biochemistry and Molecular Biology 125 1-2 2011 66 82
106. D. Ayan, R. Maltais, J. Roy, and D. Poirier A new nonestrogenic steroidal inhibitor of 17beta-hydroxysteroid dehydrogenase type I blocks the estrogen-dependent breast cancer tumor growth induced by estrone Molecular Cancer Therapeutics 11 10 2012 2096 2104
107. J.M. Day, P.A. Foster, H.J. Tutill, M.F. Parsons, S.P. Newman, S.K. Chander, G.M. Allan, H.R. Lawrence, N. Vicker, and B.V. Potter 17beta-hydroxysteroid dehydrogenase Type 1, and not Type 12, is a target for endocrine therapy of hormone-dependent breast cancer International Journal of Cancer 122 9 2008 1931 1940 (Pubitemid 351441181)
108. J. Fu, A.M. Weise, J.L. Falany, C.N. Falany, B.J. Thibodeau, F.R. Miller, T.A. Kocarek, and M. Runge-Morris Expression of estrogenicity genes in a lineage cell culture model of human breast cancer progression Breast Cancer Research and Treatment 120 1 2010 35 45
109. D.M. Lonard, R.B. Lanz, and B.W. O'Malley Nuclear receptor coregulators and human disease Endocrine Reviews 28 5 2007 575 587 (Pubitemid 47236337)
110. J. Chen, H.K. Kinyamu, and T.K. Archer Changes in attitude, changes in latitude: nuclear receptors remodeling chromatin to regulate transcription Molecular Endocrinology 20 1 2006 1 13 (Pubitemid 43011666)
111. M. Lupien, and M. Brown Cistromics of hormone-dependent cancer Endocrine-Related Cancer 16 2 2009 381 389
112. C.M. Klinge miRNAs and estrogen action Trends in Endocrinology and Metabolism 23 5 2012 223 233
113. L. Ferraro, M. Ravo, G. Nassa, R. Tarallo, M.R. De Filippo, G. Giurato, F. Cirillo, C. Stellato, S. Silvestro, and C. Cantarella Effects of oestrogen on microRNA expression in hormone-responsive breast cancer cells Hormones and Cancer 3 3 2012 65 78
114. M. Cui, Z. Wen, Z. Yang, J. Chen, and F. Wang Estrogen regulates DNA methyltransferase 3B expression in Ishikawa endometrial adenocarcinoma cells Molecular Biology Reports 36 8 2009 2201 2207
115. F. Jin, S.C. Dowdy, Y. Xiong, N.L. Eberhardt, K.C. Podratz, and S.W. Jiang Up-regulation of DNA methyltransferase 3B expression in endometrial cancers Gynecologic Oncology 96 2 2005 531 538 (Pubitemid 40127160)
116. Y. Yamagata, H. Asada, I. Tamura, L. Lee, R. Maekawa, K. Taniguchi, T. Taketani, A. Matsuoka, H. Tamura, and N. Sugino DNA methyltransferase expression in the human endometrium: down-regulation by progesterone and estrogen Human Reproduction 24 5 2009 1126 1132
117. C.A. Krusche, P. Wulfing, C. Kersting, A. Vloet, W. Bocker, L. Kiesel, H.M. Beier, and J. Alfer Histone deacetylase-1 and -3 protein expression in human breast cancer: a tissue microarray analysis Breast Cancer Research and Treatment 90 1 2005 15 23 (Pubitemid 40486997)
118. Z. Zhang, H. Yamashita, T. Toyama, H. Sugiura, Y. Ando, K. Mita, M. Hamaguchi, Y. Hara, S. Kobayashi, and H. Iwase Quantitation of HDAC1 mRNA expression in invasive carcinoma of the breast Breast Cancer Research and Treatment 94 1 2005 11 16 (Pubitemid 41416937)
119. S. Saji, M. Kawakami, S. Hayashi, N. Yoshida, M. Hirose, S. Horiguchi, A. Itoh, N. Funata, S.L. Schreiber, and M. Yoshida Significance of HDAC6 regulation via estrogen signaling for cell motility and prognosis in estrogen receptor-positive breast cancer Oncogene 24 28 2005 4531 4539 (Pubitemid 41032616)
120. O. Kovalchuk, V.P. Tryndyak, B. Montgomery, A. Boyko, K. Kutanzi, F. Zemp, A.R. Warbritton, J.R. Latendresse, I. Kovalchuk, and F.A. Beland Estrogen-induced rat breast carcinogenesis is characterized by alterations in DNA methylation, histone modifications and aberrant microRNA expression Cell Cycle (Georgetown, TX) 6 16 2007 2010 2018 (Pubitemid 47327889)
121. M. Putnik, C. Zhao, J.-A. Gustafsson, and K. Dahlman-Wright Global identification of genes regulated by estrogen signaling and demethylation in MCF-7 breast cancer cells Biochemical and Biophysical Research Communications 426 1 2012 26 32
122. K.P. Singh, J. Treas, T. Tyagi, and W. Gao DNA demethylation by 5-aza-2-deoxycytidine treatment abrogates 17 beta-estradiol-induced cell growth and restores expression of DNA repair genes in human breast cancer cells Cancer Letters 316 1 2012 62 69
123. C.K. Osborne Tamoxifen in the treatment of breast cancer New England Journal of Medicine 339 22 1998 1609 1618 (Pubitemid 28536137)
124. P. Raha, S. Thomas, and P.N. Munster Epigenetic modulation: a novel therapeutic target for overcoming hormonal therapy resistance Epigenomics 3 4 2011 451 470
125. Y.L. Ottaviano, J.P. Issa, F.F. Parl, H.S. Smith, S.B. Baylin, and N.E. Davidson Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells Cancer Research 54 10 1994 2552 2555 (Pubitemid 24173735)
126. M. Macaluso, C. Cinti, G. Russo, A. Russo, and A. Giordano pRb2/p130-E2F4/5-HDAC1-SUV39H1-p300 and pRb2/p130-E2F4/5-HDAC1-SUV39H1-DNMT1 multimolecular complexes mediate the transcription of estrogen receptor-alpha in breast cancer Oncogene 22 23 2003 3511 3517 (Pubitemid 36765310)
127. D. Sharma, J. Blum, X. Yang, N. Beaulieu, A.R. Macleod, and N.E. Davidson Release of methyl CpG binding proteins and histone deacetylase 1 from the estrogen receptor alpha (ER) promoter upon reactivation in ER-negative human breast cancer cells Molecular Endocrinology 19 7 2005 1740 1751 (Pubitemid 41007887)
128. M. Wei, J. Xu, J. Dignam, R. Nanda, L. Sveen, J. Fackenthal, T.A. Grushko, and O.I. Olopade Estrogen receptor alpha, BRCA1, and FANCF promoter methylation occur in distinct subsets of sporadic breast cancers Breast Cancer Research and Treatment 111 1 2008 113 120 (Pubitemid 352009235)
129. R.G. Lapidus, A.T. Ferguson, Y.L. Ottaviano, F.F. Parl, H.S. Smith, S.A. Weitzman, S.B. Baylin, J.P. Issa, and N.E. Davidson Methylation of estrogen and progesterone receptor gene 5′ CpG islands correlates with lack of estrogen and progesterone receptor gene expression in breast tumors Clinical Cancer Research 2 5 1996 805 810
130. M. Hori, M. Iwasaki, F. Yoshimi, Y. Asato, and M. Itabashi Hypermethylation of the estrogen receptor alpha gene is not related to lack of receptor protein in human breast cancer Breast Cancer 6 2 1999 79 86
131. H. Iwase, Y. Omoto, H. Iwata, T. Toyama, Y. Hara, Y. Ando, Y. Ito, Y. Fujii, and S. Kobayashi DNA methylation analysis at distal and proximal promoter regions of the oestrogen receptor gene in breast cancers British Journal of Cancer 80 12 1999 1982 1986 (Pubitemid 29391285)
132. L. Zhao, L. Wang, F. Jin, W. Ma, J. Ren, X. Wen, M. He, M. Sun, H. Tang, and M. Wei Silencing of estrogen receptor alpha (ERalpha) gene by promoter hypermethylation is a frequent event in Chinese women with sporadic breast cancer Breast Cancer Research and Treatment 117 2 2009 253 259
133. C.A. Encarnacion, D.R. Ciocca, W.L. McGuire, G.M. Clark, S.A. Fuqua, and C.K. Osborne Measurement of steroid hormone receptors in breast cancer patients on tamoxifen Breast Cancer Research and Treatment 26 3 1993 237 246 (Pubitemid 23304239)
134. H.W. van den Berg, M. Lynch, J. Martin, J. Nelson, G.R. Dickson, and A.D. Crockard Characterisation of a tamoxifen-resistant variant of the ZR-75-1 human breast cancer cell line (ZR-75-9a1) and ability of the resistant phenotype British Journal of Cancer 59 4 1989 522 526 (Pubitemid 19111740)
135. S.R. Johnston, G. Saccani-Jotti, I.E. Smith, J. Salter, J. Newby, M. Coppen, S.R. Ebbs, and M. Dowsett Changes in estrogen receptor, progesterone receptor, and pS2 expression in tamoxifen-resistant human breast cancer Cancer Research 55 15 1995 3331 3338
136. T. Kuukasjarvi, J. Kononen, H. Helin, K. Holli, and J. Isola Loss of estrogen receptor in recurrent breast cancer is associated with poor response to endocrine therapy Journal of Clinical Oncology 14 9 1996 2584 2589 (Pubitemid 26300127)
137. A.T. Ferguson, R.G. Lapidus, S.B. Baylin, and N.E. Davidson Demethylation of the estrogen receptor gene in estrogen receptor-negative breast cancer cells can reactivate estrogen receptor gene expression Cancer Research 55 11 1995 2279 2283
138. X. Yang, A.T. Ferguson, S.J. Nass, D.L. Phillips, K.A. Butash, S.M. Wang, J.G. Herman, and N.E. Davidson Transcriptional activation of estrogen receptor alpha in human breast cancer cells by histone deacetylase inhibition Cancer Research 60 24 2000 6890 6894 (Pubitemid 32059160)
139. X. Yang, D.L. Phillips, A.T. Ferguson, W.G. Nelson, J.G. Herman, and N.E.
140. J. Fan, W.J. Yin, J.S. Lu, L. Wang, J. Wu, F.Y. Wu, G.H. Di, Z.Z. Shen, and Z.M. Shao ER alpha negative breast cancer cells restore response to endocrine therapy by combination treatment with both HDAC inhibitor and DNMT inhibitor Journal of Cancer Research and Clinical Oncology 134 8 2008 883 890
141. K.T. Huynh, K.K. Chong, E.S. Greenberg, and D.S. Hoon Epigenetics of estrogen receptor-negative primary breast cancer Expert Review of Molecular Diagnostics 12 4 2012 371 382
142. P.N. Munster, K.T. Thurn, S. Thomas, P. Raha, M. Lacevic, A. Miller, M. Melisko, R. Ismail-Khan, H. Rugo, and M. Moasser A phase II study of the histone deacetylase inhibitor vorinostat combined with tamoxifen for the treatment of patients with hormone therapy-resistant breast cancer British Journal of Cancer 104 12 2011 1828 1835
143. J. Drappatz, E.Q. Lee, S. Hammond, S.A. Grimm, A.D. Norden, R. Beroukhim, M. Gerard, D. Schiff, A.S. Chi, and T.T. Batchelor Phase I study of panobinostat in combination with bevacizumab for recurrent high-grade glioma Journal of Neuro-Oncology 107 1 2012 133 138
144. M. Kubo, N. Kanaya, K. Petrossian, J. Ye, C. Warden, Z. Liu, R. Nishimura, T. Osako, M. Okido, and K. Shimada Inhibition of the proliferation of acquired aromatase inhibitor-resistant breast cancer cells by histone deacetylase inhibitor LBH589 (panobinostat) Breast Cancer Research and Treatment 2012
145. D. Yardley, R. Ismail-Khan, and P. Klein Entinostat, A novel histone deacetylase inhibitor, added to exemestane improves PFS in advanced breast cancer in a randomized, phase II, double-blind study Cancer Research 71 24 (Suppl.) 2011 Abstract nr PD01-04
146. Y. Oki, and J.P. Issa Review: recent clinical trials in epigenetic therapy Reviews on Recent Clinical Trials 1 2 2006 169 182